Taking Action

Author | Lauren Crawford

Photo by Scott C. Soderberg, Michigan Photography

When Ella Kazerooni (M.D. 1988, Residency 1992) was a resident, she presented an abstract at an abdominal radiology meeting and caught the attention of a leader in the field. He was impressed by her research and wanted to know if she had decided on a specialty. Kazerooni's response of "chest radiology" garnered a less-than-enthusiastic reaction, she remembers, but she was unfazed. "Most of the action, in terms of impacting public health," she recalls telling him, resolutely, while framing her own chest, "is here in the heart and lungs." 

This area, to which "the leading causes of mortality in the U.S. can be attributed," is where Kazerooni, now professor of radiology and of internal medicine, has established herself as an innovator and advocate. In fact, she helped design, initiate and implement one of the nation's most comprehensive studies on lung cancer screening, a disease burdened by misinformation and stigma. 

"Navigating that stigma is important," Kazerooni stresses. "We have a lot of myths to overcome. There's an 'I did this to myself' mentality, or people think, 'I don't deserve to have this benefit.'" 

But they do, and the study, funded by the National Institutes of Health (NIH) and facilitated by the American College of Radiology, has proven that annual screening does indeed help reduce mortality and is cost-effective when compared to other screening tests. The study was so successful that its efficacy was publicly proclaimed before the scheduled end-date. 

"I still remember the day," Kazerooni muses happily. "There was this announcement that the trial was stopped — the Data and Safety Monitoring Board had reached a conclusion that the results were definitive early. They made a public announcement at a press conference held at the NIH, which is a very unusual way to release the results of a research trial." 

It's a conclusion of which Kazerooni, also the associate chair for clinical affairs in the Department of Radiology, director of cardiothoracic radiology and service chief of diagnostic radiology, is immensely proud. She became a chest radiologist (now known as a cardiothoracic radiologist) because she felt she could effect the most change for the largest number of people. Caring for a population that was once overlooked or blamed for their condition is one of the most impactful and profound ways she is fulfilling her dream. 

There are still barriers to negotiate — among them uncertainty in funding from the changing health care environment — but the landmark study has germinated much more research, a majority of which Kazerooni and her team are heading. Currently, they're looking into ways to communicate medical information to patients more effectively and in a more personalized manner. More broadly, the study prompted health care centers across the country to follow U-M's lead, and, collectively, institutions are inputting their data into a national data registry for lung cancer screening. Kazerooni is chairing this effort.

"We're in this phase of widespread early implementation. Analyzing the registry data will help us understand if the benefit shown in the research trial of over 50,000 subjects can be brought successfully to the population at risk not only of lung cancer, but of heart disease and COPD — other conditions the screening CTs detect."

The registry is also measuring patient outcomes and rating the radiologists' performances to "constantly review and improve" quality.

As chair of the American Cancer Society's lung cancer screening roundtable, Kazerooni feels privileged to have seen the eight-year-long trial conclude and succeed in such a demonstrably favorable way. However, she's eager for the next steps: "We want to make sure that high quality screening is available to all who might benefit from it. We want to make lung cancer survivors."


More Articles About: Radiology NIH advocacy lung cancer screening Research trials
Featured News & Stories The Fundamentals Podcast Hero Card Final 1800 x 1350
The Fundamentals
Treating Diabetes & Weight: The Ozempic & Wegovy Effect
Today on The Fundamentals, our guest Dr. Martin Myers, Director of the U-M Elizabeth Weiser Caswell Diabetes Institute, discusses diabetes research in the context of Ozempic, Wegovy, and other drugs that are changing how people think about weight loss. You can learn more about Dr. Myers here, and you can follow the department of molecular and integrative physiology @UMPhysiology on X.
The Fundamentals Podcast Hero Card Final 1800 x 1350
The Fundamentals
Can AI Make Us Healthier Humans?
Dr. Jody Platt. She is an Associate Professor of Learning Health Sciences at the University of Michigan Medical School. Trained in medical sociology and health policy, her research focuses on issues at the intersection of informatics and ethics. She is interested in understanding what makes data-driven health trusted, and the pathways for earning, achieving, and sustaining trust across stakeholders. Dr. Platt is the Academy Health and ABIM Foundation Senior Scholar in Residence advising on issues of measuring and building trust.
The Fundamentals Podcast Hero Card Final 1800 x 1350
The Fundamentals
From Patients to Progress: Advancing Autoimmune Research
Today on The Fundamentals, our guest is Dr. Michelle Kahlenberg, an Associate Professor of Internal Medicine and Dermatology, the Giles Bole and Dorothy Mulkey Research Professor of Rheumatology and the Vice Chair for Basic and Translational Research in Internal Medicine. Her clinical work is centered on the care of patients with lupus, including those with refractory skin disease. In addition to running her lab, she's an active member of the Immunology Training Program and has received national recognition for her research.
The Fundamentals Podcast Hero Card Final 1800 x 1350
The Fundamentals
Addiction is a lifelong disease and not a moral failing
On today’s The Fundamentals is Dr. Brummett, Professor at the University of Michigan where he serves as the Senior Associate Chair for Research in the Department of Anesthesiology. He has more than 280 publications, including articles in top journals such as JAMA, JAMA Surgery, Anesthesiology, and Annals of Surgery. He is the Co-Director of the Opioid Prescribing Engagement Network or OPEN at the University of Michigan, which aims to apply a preventative approach to the opioid epidemic in the US through appropriate prescribing after surgery, dentistry and emergency medicine. Moreover, he is the Co-Director of the cross-campus Opioid Research Institute, which was launched in the spring of 2023. He leads multiple NIH grants studying these concepts and receives funding from the Michigan Department of Health and Human Services, SAMHSA, CDC, and multiple foundations. You can learn more about Dr. Brummett here, and you can follow Dr. Brummett @drchadb and the department of anesthesiology @UMichAnesthesia on X.
Physician holds model of prostate and points to it for patient
Health Lab
5 things to know about prostate enlargement and treatment options
Interventional radiologist provides information on benign prostatic hyperplasia, effectiveness of available procedures
Minding Memory with a microphone and a shadow of a microphone on a blue background
Minding Memory
The Intersection of Artificial Intelligence & Alzheimer’s Disease and Related Dementias
In this episode, Matt and Donovan talk with Dr. Jason H. Moore, Director of the Center for Artificial Intelligence Research and Education (CAIRE) and Chair of the Department of Computational Biomedicine at Cedars-Sinai Medical Center. Jason discusses the coming impact of artificial intelligence on a spectrum of Alzheimer’s disease and related dementia (ADRD) issues. We discuss how tools such as AI-powered chatbots may improve quality of life for people living with dementia (and their caregivers) and how AI may contribute in the future to diagnosis and treatment.